Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1451 (17 June), doi:10.1136/bmj.332.7555.1451-a
| The first 150 words of the full text of this article appear below. |
EDITORHarnden et al's study raises important questions about the role of prehospital parenteral penicillin in children with meningococcal disease.1 Their paper and accompanying statistical comment have shown the potential importance of excluding patients who would never have been considered for treatment. However, their study design is likely to have excluded a group of children with suspected meningococcal disease who were given prehospital parenteral penicillin.
Public health guidelines recommend that general administer prehospital parenteral penicillin to patients with suspected meningococcal disease, though the guidelines do not make specific recommendations about the clinical criteria on which general practitioners should base their decision.2 Recent research shows that clinical features other than haemorrhagic rash can be important in identifying meningococcal disease,3 reinforcing how difficult clinical decisions can be when treating an acutely unwell child.
In contrast, the formal case definition for meningococcal disease is decided after consultation between hospital clinician, microbiologist, and
D Graham Mackenzie, specialist registrar in public health
gm@nhs.net, Cameron House, Windygates, Leven, Fife KY8 5RG
Charles J P Saunders, consultant in public health medicine
Cameron House, Windygates, Leven, Fife KY8 5RG
Diptendu N Bhattacharyya, infectious disease consultant, Chris R Steer, consultant paediatrician
Hayfield House, Kirkcaldy, Fife KY2 5AH